Article in Journal of immunology (Baltimore, Md. : 1950), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.4field-weighted citation impact, top 43% of its field
1 · What the graph read from it
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registry
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literature
Who cites it
4 citing papers in PubMed, 6 citations in OpenAlex.
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what money
Authors and funding
8 authors at 2 institutions in 1 country.
Prachi BagadiaDepartment of Oncology, Amgen Inc., South San Francisco, CA.
Kevin W O'ConnorDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0002-5542-405X
Renee WuDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0002-9521-1657
Stephen T FerrisDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0003-3340-2607
Jeffrey P WardDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.ORCID 0000-0002-9707-895X
Robert D SchreiberDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.
Theresa L MurphyDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO.
Kenneth M MurphyDepartment of Pathology and Immunology, Washington University School of Medicine, St. Louis, MO; kmurphy@wustl.edu.ORCID 0000-0002-3505-9630
Washington University in St. Louis · USAmgen (United States) · US
Funding
Washington University Center for Cellular ImagingP30CA091842 · NCI · WASHINGTON UNIVERSITY · PI TIMOTHY J. EBERLEIN · 2001 to 2026
$128.0M
WU INSTITUTE OF CLINICAL AND TRANSLATIONAL SCIENCESUL1TR002345 · NCATS · WASHINGTON UNIVERSITY · PI William G. Powderly · 2017 to 2026
$97.8M
Washington University Institute of Clinical and Translational SciencesUL1TR000448 · NCATS · WASHINGTON UNIVERSITY · PI EVANOFF, BRADLEY A · 2012 to 2016
$41.4M
Washington University Rheumatic DiseasesResearch Resource-based CenterP30AR073752 · NIAMS · WASHINGTON UNIVERSITY · PI Deborah J Lenschow, Christine T. Pham · 2018 to 2026
$7.6M
Molecular Basis of cDC1 DevelopmentR01AI162643 · NIAID · WASHINGTON UNIVERSITY · PI MURPHY, KENNETH M · 2022 to 2025
$2.8M
Function of Wdfy4 in cross-presentation and immunityR01AI150297 · NIAID · WASHINGTON UNIVERSITY · PI MURPHY, KENNETH M · 2019 to 2023
$2.5M
Understanding the Mechanisms of DC Licensing in CD8 T Cell PrimingR01CA248919 · NCI · WASHINGTON UNIVERSITY · PI MURPHY, KENNETH M · 2021 to 2025
$2.3M
The role of type 1 dendritic cells in CD4 and CD8 T cell anti-tumor immunityF30CA247262 · NCI · WASHINGTON UNIVERSITY · PI WU, RENEE PAULA · 2021 to 2023
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.